AYUSH – GCP Dr Sathiya Rajeswaran Research Officer SCRI,CCRS,Chennai All roads meet a common goal Roads are different goal is same • ICMR • WHO. ‘Good Clinical Practice Guidelines’ published by AYUSH Ministry for clinical trials of Ayurveda, Siddha & Unani drugs. There are four Research. The department of Ayush has issued good clinical practice (GCP) guidelines for clinical trials in Ayurveda, Siddha and Unani (ASU) medicines.

Author: Kell Zololar
Country: Seychelles
Language: English (Spanish)
Genre: Marketing
Published (Last): 15 January 2004
Pages: 134
PDF File Size: 17.5 Mb
ePub File Size: 10.79 Mb
ISBN: 439-1-65963-190-4
Downloads: 14752
Price: Free* [*Free Regsitration Required]
Uploader: Dogal

Applications of Ayurveda to chronic disease therefore satisfy the third criterion. The first criterion requires compelling arguments, or reasons supporting a atush efficacy of the treatment in question. Traditional medicine and genomics. In the conventional RCT model, efficacy is often determined before assessing effectiveness, which is now considered unethical.

The guidelines seek to establish two cardinal principles: Conceptual framework for new models of integrative medicine. Apr 22, 6: However, blinding of the outcomes to the evaluators can ensure an unbiased comparison.

These studies should be intended to provide an adequate basis for marketing approval for ASU Drugs. Help Center Find new research papers in: Miller FG, Joffe S. The case of Ayurveda, however, is different as the treatment regimen is already in use.

The fourth criterion requires a historical control group. Skip to main content.

A proposed new discipline. System to be followed for labelling of the product s code numbering etc. Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: Such studies are generally performed in later Phases but may be appropriate when drug activity is readily measurable with a short duration of drug exposure in patients at this early stage. The tuidelines ASU guidelines are expected to generate a body of clinical research based on bioethics, transparency in reporting, and lack of scientific bias.


Log In Sign Up. Inhibition of mutated, activated BRAF in metastatic melanoma. This is how many drugs have found place in modern medicine, the best example being aspirin, where its anti-inflammatory and analgesic properties were recognized long before its mechanism of influencing prostaglandin synthesis was understood. In order to post comments, please make sure JavaScript and Cookies are enabled, and reload the page.

Support Center Support Ayusj. The question of whether treatment is drug-based, or herbal, or other is irrelevant. However, all paediatric participants should be informed to the fullest extent possible about the study in a language and in terms that they are able to understand.

Researchers, sponsors and drug manufacturers, therefore, have to be well versed with the standard scientific procedures that are required to be followed while conducting clinical trials with ASU interventions to achieve objective and reproducible results. The Ayurvedic system of medicine has survived and thrived over a long period of time, which is an indication that it works. These suggestions have a significant relevance for Ayurveda, especially because of its potential efficacy against chronic diseases, of which some, but not all, may be fatal.

Remember me on this computer. Studies in Phase III may also further explore the dose-response relationships relationships among dose, and clinical responseuse of the drug in wider populations in different stages of disease, gco the safety and efficacy of the drug in combination with other drug s.

Regulation on AYUSH system of Good Clinical Practice Guidelines | Business Standard News

Researchers have voiced this view in several countries over the last few years. Apr 19, 1: Enter the email address you cgp up with and we’ll email you a reset link. Recommending equivalence trial design and proposing safety index. Researching complementary and alternative treatments – the gatekeepers are not at home.



In addition, patients would gain solace from being given rightful access to safe and affordable healthcare. Type 1 error minimizes the chances of releasing a bad drug into the market and power maximizes the chance of discovering a ayusn drug.

For not only have medical researchers questioned the process but some leading doctors have directly written to the Drug Controller of India to ban its use.

Dr Ramesh Rajguru Apr 18, 5: To summarize, when the world is waking up and seriously debating the need for newer models for clinical research, Indian guidelines for ASU should not get overwhelmed by the RCT approach of biomedicine. A noxious and unintended response at doses normally used or tested in humans b Ayysh case of new unregistered ASU Medicines: Well controlled, double-blind, placebo-controlled trials of classical Ayurvedic treatment are possible in rheumatoid arthritis.

They should be followed for carrying out all ASU medicine research in India at all stages of drug development, whether prior or subsequent to product registration in India.

Regulation on AYUSH system of Good Clinical Practice Guidelines

The objective of this page log document is to encourage that clinical studies in ASU systems are undertaken in accordance with ethical and scientific standards and safety aspects and rights of participants are protected.

However, these guidelines are for voluntary use by the researchers interested in taking up clinical trials by using ASU medicine. To foster good clinical research, it is greatly desired that the principles driving these guidelines should be ethics, transparency and scientific unbiasedness.


Your email address will not be published. Such trials may also evaluate whole system interventions implemented under defined manuals and protocols, to specify individualized treatments based on specific patient characteristics.

In case of Ayurveda for instance, patients are already using its treatments and therefore effectiveness studies can guide the necessity of studying the efficacy of specific components.

The black box approach, pragmatic trials, and the whole system approach of Ayurveda needs to be maintained rather than accepting reductionist methods of treating any symptom or disease condition in isolation.